OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diabetes and Frailty: An Expert Consensus Statement on the Management of Older Adults with Type 2 Diabetes
W. David Strain, Su Down, Pam Brown, et al.
Diabetes Therapy (2021) Vol. 12, Iss. 5, pp. 1227-1247
Open Access | Times Cited: 127

Showing 1-25 of 127 citing articles:

Type 2 diabetes
Ehtasham Ahmad, Soo Lim, Roberta Lamptey, et al.
The Lancet (2022) Vol. 400, Iss. 10365, pp. 1803-1820
Closed Access | Times Cited: 557

Comparative Cardiovascular Effectiveness and Safety of SGLT-2 Inhibitors, GLP-1 Receptor Agonists, and DPP-4 Inhibitors According to Frailty in Type 2 Diabetes
Alexander Kutz, Dae Hyun Kim, Deborah J. Wexler, et al.
Diabetes Care (2023) Vol. 46, Iss. 11, pp. 2004-2014
Open Access | Times Cited: 41

Management of Type 2 Diabetes Mellitus in Elderly Patients with Frailty and/or Sarcopenia
Jaime Sanz‐Cánovas, Almudena López‐Sampalo, Lidia Cobos-Palacios, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 14, pp. 8677-8677
Open Access | Times Cited: 54

A Proposed Curricular Framework for an Interprofessional Approach to Deprescribing
Barbara Farrell, Lalitha Raman‐Wilms, Cheryl A Sadowski, et al.
Medical Science Educator (2023) Vol. 33, Iss. 2, pp. 551-567
Open Access | Times Cited: 25

Sodium-glucose cotransporter-2 inhibitors (SGLT2) in frail or older people with type 2 diabetes and heart failure: a systematic review and meta-analysis
Rami Aldafas, Thomas Crabtree, Mohammed Alkharaiji, et al.
Age and Ageing (2024) Vol. 53, Iss. 1
Open Access | Times Cited: 13

Network analysis of depressive and anxiety symptoms in older Chinese adults with diabetes mellitus
Yajuan Zhang, Yi Cui, Yijun Li, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 9

Guideline for the Management of Diabetes Mellitus in the Elderly in China (2024 Edition)
Lixin Guo, Xinhua Xiao
Aging Medicine (2024) Vol. 7, Iss. 1, pp. 5-51
Open Access | Times Cited: 8

Fracture risk following bariatric surgery: a systematic review and meta-analysis
Randa Saad, M. Ghezzawi, Dalal Habli, et al.
Osteoporosis International (2022) Vol. 33, Iss. 3, pp. 511-526
Closed Access | Times Cited: 36

Frailty and diabetes in older adults: Overview of current controversies and challenges in clinical practice
mariam arif, Mark O’Donovan, Duygu Sezgin, et al.
Frontiers in Clinical Diabetes and Healthcare (2022) Vol. 3
Open Access | Times Cited: 35

The role of sodium-glucose co-transporter-2 inhibitors in frail older adults with or without type 2 diabetes mellitus
Marc Evans, Angharad R. Morgan, Sarah Davies, et al.
Age and Ageing (2022) Vol. 51, Iss. 10
Open Access | Times Cited: 29

Efficacy and safety profile of SGLT2 inhibitors in the elderly: How is the benefit/risk balance?
André Scheen, Fabrice Bonnet
Diabetes & Metabolism (2023) Vol. 49, Iss. 2, pp. 101419-101419
Open Access | Times Cited: 20

Clinical impacts of frailty on 123,172 people with diabetes mellitus considering the age of onset and drugs of choice: a nationwide population-based 10-year trajectory analysis
Shih‐Tsung Huang, Liang‐Kung Chen, Fei‐Yuan Hsiao
Age and Ageing (2023) Vol. 52, Iss. 7
Closed Access | Times Cited: 18

What are the consequences of over and undertreatment of type 2 diabetes mellitus in a frail population? A systematic review
Helen O’Neil, Adam Todd, Mark S. Pearce, et al.
Endocrinology Diabetes & Metabolism (2024) Vol. 7, Iss. 2
Open Access | Times Cited: 7

SGLT2 Inhibitors – The New Standard of Care for Cardiovascular, Renal and Metabolic Protection in Type 2 Diabetes: A Narrative Review
Samuel Seidu, Vicki Alabraba, Sarah Davies, et al.
Diabetes Therapy (2024) Vol. 15, Iss. 5, pp. 1099-1124
Open Access | Times Cited: 7

Type 2 Diabetes and Impaired Physical Function: A Growing Problem
Ehtasham Ahmad, Jack A. Sargeant, Tom Yates, et al.
Diabetology (2022) Vol. 3, Iss. 1, pp. 30-45
Open Access | Times Cited: 27

Diuretics, SGLT2 inhibitors and falls in older heart failure patients: to prescribe or to deprescribe? A clinical review
Eveline P. van Poelgeest, M. Louis Handoko, Majon Muller, et al.
European Geriatric Medicine (2023) Vol. 14, Iss. 4, pp. 659-674
Open Access | Times Cited: 15

Healthy aging, early screening, and interventions for frailty in the elderly
Yi Deng, Keming Zhang, Jiali Zhu, et al.
BioScience Trends (2023) Vol. 17, Iss. 4, pp. 252-261
Open Access | Times Cited: 13

Healthy aging and chronic kidney disease
Reshma Aziz Merchant, Anantharaman Vathsala
Kidney Research and Clinical Practice (2022) Vol. 41, Iss. 6, pp. 644-656
Open Access | Times Cited: 19

Prevalence and risk factors of frailty in older adults with diabetes: A systematic review and meta-analysis
Yaqing Liu, L. Zhang, Xiaoyun Li, et al.
PLoS ONE (2024) Vol. 19, Iss. 10, pp. e0309837-e0309837
Open Access | Times Cited: 4

Age and Sex Differences in Efficacy of Treatments for Type 2 Diabetes
Peter Hanlon, Elaine Butterly, Lili Wei, et al.
JAMA (2025)
Closed Access

Page 1 - Next Page

Scroll to top